Medicine and Dentistry
Health Care Cost
100%
Bladder Cancer
58%
Surveillance
33%
Patient
33%
Therapeutic Procedure
25%
Diseases
16%
Cisplatin
16%
Combination Therapy
16%
Diagnosis
16%
Bladder Tumor
16%
Non Muscle Invasive Bladder Cancer
16%
Systematic Review
16%
Neoplasm
8%
Metastatic Carcinoma
8%
Morbidity
8%
Fulguration
8%
Cystectomy
8%
Transitional Cell Carcinoma
8%
Recurrent Disease
8%
Transurethral Resection
8%
Gemcitabine
8%
Vinblastine
8%
Doxorubicin
8%
Perioperative Period
8%
Disease Severity
8%
Methotrexate
8%
Postoperative Care
8%
Recurrence Risk
8%
Cancer Therapy
8%
Evaluation Study
8%
Nursing and Health Professions
Bladder Cancer
58%
Diseases
16%
Perioperative
16%
Diagnosis
16%
Combination Therapy
16%
Medical Subject Headings
16%
Non Muscle Invasive Bladder Cancer
16%
Electric Potential
16%
Inpatient
16%
Cisplatin
16%
Bladder Tumor
16%
Medline
8%
Morbidity
8%
Perioperative Period
8%
Cost Effectiveness Analysis
8%
Length of Stay
8%
Recurrent Disease
8%
Transitional Cell Carcinoma
8%
Cystectomy
8%
Metastasis
8%
Neoplasm
8%
Chemotherapy
8%
Cost Control
8%
Disease Severity
8%
Postoperative Care
8%
Recurrence Risk
8%
Terminal Care
8%
Cancer Therapy
8%
Evaluation Study
8%
Procedures
8%
Synthesis
8%
Cauterization
8%
Doxil
8%
Methotrexate
8%
Transurethral Resection
8%
Gemcitabine
8%
Vinblastine
8%